Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus).
D000818:Animals; D000965:Antimony / Q000627:therapeutic use* / Q000633:toxicity; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001029:Aotus trivirgatus / Q000469:parasitology*; D002427:Cebidae / Q000469:parasitology*; D005260:Female; D007896:Leishmaniasis / Q000188:drug therapy / Q000662:veterinary*; D008297:Male; D008536:Meglumine; D000077485:Meglumine Antimoniate; D008992:Monkey Diseases / Q000188:drug therapy*; D009942:Organometallic Compounds
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony